Hiroshi Matsuoka Selected Research

Hiroshi Matsuoka Research Topics

Disease

36	Neoplasms (Cancer) 04/2022 - 11/2002
21	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 08/2004
10	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2007
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 01/2015
7	Rectal Neoplasms (Rectal Cancer) 12/2020 - 11/2002
6	Stroke (Strokes) 01/2022 - 01/2015
6	Infections 11/2020 - 11/2002
6	Thrombosis (Thrombus) 06/2019 - 01/2010
5	Lymphoma (Lymphomas) 09/2019 - 12/2016
4	Leukemia 10/2019 - 01/2011
3	Hemorrhage 04/2022 - 10/2017
3	Disease Progression 11/2021 - 10/2013
3	Anemia 12/2020 - 03/2019
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 10/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 07/2019 - 10/2008
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2019 - 06/2011
3	Neutropenia 01/2019 - 10/2013
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2014
3	Acute Coronary Syndrome 01/2019 - 08/2016
3	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 08/2013
3	Heart Failure 08/2018 - 02/2013
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2012 - 10/2008
3	Melanoma (Melanoma, Malignant) 10/2009 - 01/2007
2	Myocardial Infarction 01/2022 - 06/2005
2	Carcinogenesis 02/2021 - 01/2007
2	Pathologic Constriction (Stenosis) 01/2021 - 08/2009
2	Atherosclerosis 01/2021 - 04/2020
2	Splenomegaly 12/2020 - 09/2019
2	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 04/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2019 - 02/2013
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2019 - 04/2009
2	Hypersensitivity (Allergy) 05/2017 - 01/2015
2	Hypertension (High Blood Pressure) 08/2016 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2016 - 08/2013
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2015 - 01/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2012 - 11/2010
2	Pancytopenia 01/2012 - 01/2011
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2011 - 03/2009

Drug/Important Bio-Agent (IBA)

7	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 11/2002
5	Bevacizumab (Avastin)FDA Link 11/2021 - 10/2013
5	Leucovorin (Folinic Acid)FDA Link 11/2021 - 11/2002
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2017 - 10/2013
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2007
4	CholesterolIBA 05/2020 - 01/2015
4	XELOXIBA 05/2017 - 01/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2019
3	Capecitabine (Xeloda)FDA Link 11/2021 - 01/2015
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 01/2018
3	Voriconazole (Vfend)FDA LinkGeneric 11/2019 - 01/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2019 - 06/2011
3	Peptides (Polypeptides)IBA 01/2018 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 02/2017 - 07/2013
3	Monoclonal AntibodiesIBA 01/2017 - 07/2002
3	SteroidsIBA 12/2016 - 03/2009
2	regorafenibIBA 11/2021 - 02/2021
2	trifluridine tipiracil drug combinationIBA 11/2021 - 01/2019
2	BariumIBA 05/2021 - 06/2005
2	Phosphotransferases (Kinase)IBA 02/2021 - 09/2019
2	ClaudinsIBA 01/2021 - 10/2017
2	EnzymesIBA 09/2020 - 05/2020
2	Small Interfering RNA (siRNA)IBA 05/2020 - 04/2020
2	Immunoglobulins (Immunoglobulin)IBA 04/2020 - 09/2012
2	Gemtuzumab (Mylotarg)FDA Link 10/2019 - 11/2018
2	AntigensIBA 09/2019 - 08/2004
2	Rituximab (Mabthera)FDA Link 03/2019 - 04/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2019 - 01/2015
2	Tolvaptan FDA Link 02/2018 - 02/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 09/2010
2	Sirolimus (Rapamycin)FDA Link 05/2017 - 08/2009
2	nuclear pore complex protein 98IBA 01/2016 - 03/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 01/2008
2	oxidized low density lipoproteinIBA 12/2014 - 09/2010
2	Organic Cation Transporter 2IBA 01/2014 - 01/2014
2	Organic Anion TransportersIBA 01/2014 - 07/2013
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2009 - 10/2008
2	Indicators and Reagents (Reagents)IBA 07/2009 - 08/2004
2	Protein Kinase CIBA 07/2009 - 01/2007
2	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2004 - 08/2004
2	Thymidylate SynthaseIBA 10/2004 - 08/2004
2	ParaffinIBA 10/2004 - 08/2004
1	AnthracyclinesIBA 10/2022

Therapy/Procedure

25	Therapeutics 10/2022 - 11/2002
22	Drug Therapy (Chemotherapy) 04/2022 - 11/2002
6	Stents 01/2019 - 03/2005
5	Chemoradiotherapy 12/2020 - 11/2009
4	Hematopoietic Stem Cell Transplantation 01/2022 - 06/2011
3	Lymph Node Excision (Lymph Node Dissection) 03/2020 - 11/2015
3	Stem Cell Transplantation 03/2019 - 02/2013
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2019 - 01/2015
3	Percutaneous Coronary Intervention 01/2019 - 10/2017
2	Colectomy 04/2022 - 02/2014
2	Catheters 06/2019 - 11/2002
2	Hepatectomy 02/2019 - 03/2018
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2019 - 02/2013
2	Aftercare (After-Treatment) 02/2019 - 12/2015
2	Adjuvant Chemotherapy 05/2017 - 10/2004
2	Neoadjuvant Therapy 01/2017 - 04/2013
2	Radiotherapy 11/2012 - 11/2008